[ 1 ] Levi M. Disseminated intravascular coagulation[J]. Crit Care Med, 2007, 35(9): 2191-2195.
[2]
[ 2 ] Franchini M, Di Minno MN, Coppola A. Disseminated intravascular coagulation in hematologic malignancies[J]. Semin Thromb Hemost, 2010, 36(4): 388-403.
[3]
[ 3 ] Tokar M, Bobilev D, Ariad S, et al. Disseminated intravascular coagulation at presentation of advanced gastric cancer[J]. Isr Med Assoc J, 2006, 8(12): 853-855.
[4]
[ 4 ] Lin PH, Lu YS, Lin CH, et al. Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation[J]. Anticancer Res, 2010, 30(7): 3087-3091.
[5]
[ 5 ] Mizota A, Shitara K, Kondo C, et al. A case of heavily pretreated rectal cancer with disseminated intravascular coagulation that improved following reintroduction of FOLFOX plus bevacizumab[J]. Int J Clin Oncol, 2011, 16(6): 766-769.
[6]
[ 6 ] Schlaeppi MR, Korte W, von Moos R, et al. Successful treatment of acute disseminated intravascular coagulation in a patient with metastatic melanoma[J]. Onkologie, 2006, 29(11): 531-533.
[7]
[ 7 ] Green D. Management of bleeding complications of hematologic malignancies[J]. Semin Thromb Hemost, 2007, 33(4): 427-434.
[8]
[ 8 ] Dalainas I. Pathogenesis, diagnosis, and management of disseminated intravascular coagulation: a literature review[J]. Eur Rev Med Pharmacol Sci, 2008, 12(1): 19-31.
[9]
[ 9 ] Saba HI, Morelli GA. The pathogenesis and management of disseminated intravascular coagulation[J]. Clin Adv Hematol Oncol, 2006, 4(12): 919-926.
[10]
Saba HI, Morelli GA, Saba RI. Disseminated intravascular coagulation (DIC) in cancer[J]. Cancer Treat Res, 2009, 148(2): 137-156.
[11]
Li L, Han DK, Lu J. Interferon-alpha induced severe thrombocytopenia: a case report and review of the literature[J]. World J Gastroenterol, 2010, 16(11): 1414-1417.
[12]
Sakurazawa T, Ohkusa T, Fujimoto H, et al. A case of disseminated intravascular coagulation (DIC) during interferon-alpha treatment of chronic hepatitis C[J]. Nihon Shokakibyo Gakkai zasshi, 1997, 94(6): 429-433.
[13]
Akamatsu S, Asazuma A, Kanamaru S, et al. Immune thrombocytopenia during interferon-alfa therapy for renal cell carcinoma[J]. Hinyokika Kiyo, 2006, 52(10): 789-792.
[14]
Wazny LD, Ariano RE. Evaluation and management of drug-induced thrombocytopenia in the acutely ill patient[J]. Pharmacotherapy, 2000, 20(3): 292-307.
